Clinical trial
Effectiveness of Intensively Integrated Care of Microvascular Risk Factors to Prevent Diabetic Kidney Disease Incidences in Community Clinics in Xiamen, China: An Open-label Randomized Controlled Trial
NCT04988581 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Intensively Integrated Care of Microvascular Risk Factors to Prevent Diabetic Kidney Disease Incidences in Community Clinics in Xiamen, China: An Open-label Randomized Controlled Trial
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2021
- Completion date
- December 31, 2024
- Enrollment
- 1,240 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.